XORTX Therapeutics Inc. (XRTX.V)
CAD 1.62
(-7.43%)
CAD 1.62
(-7.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 188.54 Thousand | 75.26 Thousand | 17.88 Thousand | 20.43 Thousand | 19.9 Thousand | 19.31 Thousand |
| Gross Profit | -188.54 Thousand | -75.26 Thousand | -17.88 Thousand | -20.43 Thousand | -19.9 Thousand | -19.31 Thousand |
| Operating Expenses | 6.38 Million | 9.86 Million | 2.86 Million | 1.3 Million | 565.96 Thousand | 1.15 Million |
| Selling, General and Administrative Expenses | 3.17 Million | 2.29 Million | 1.58 Million | 1.09 Million | 506.16 Thousand | 795.65 Thousand |
| Research and Development Expenses | 3.2 Million | 6.48 Million | 669.1 Thousand | 277.45 Thousand | 39.89 Thousand | 342.25 Thousand |
| Other Expenses | - | - | - | - | - | -2.63 Million |
| Cost and Expenses | 6.38 Million | 9.86 Million | 2.86 Million | 1.3 Million | 565.96 Thousand | 1.15 Million |
| Operating Income | -6.38 Million | -10.68 Million | -4.13 Million | -1.3 Million | -565.96 Thousand | -1.15 Million |
| Interest Expense | - | - | 4390.52 | 13.51 Thousand | 37.21 Thousand | 22.29 Thousand |
| Income Tax Expense | - | - | 4390.52 | 13.51 Thousand | 37.21 Thousand | 22.29 Thousand |
| Earnings before Tax | -2.85 Million | -6.98 Million | -1.29 Million | -1.28 Million | -629.57 Thousand | -3.77 Million |
| Net Income | -2.85 Million | -6.98 Million | -1.29 Million | -1.28 Million | -629.57 Thousand | -3.77 Million |
| Earnings Per Share Basic | -1.44 | -4.72 | -1.19 | -1.73 | -1.06 | -6.45 |
| Earnings Per Share Diluted | -1.44 | -4.72 | -1.19 | -1.73 | -1.06 | -6.45 |
| Weighted Average Shares Outstanding | 1.98 Million | 1.47 Million | 1.09 Million | 740.44 Thousand | 595.49 Thousand | 584.98 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.98 Million | 1.47 Million | 1.09 Million | 740.44 Thousand | 595.49 Thousand | 584.98 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -6.46 Million | -9.41 Million | -1.62 Million | -1.25 Million | -572.46 Thousand | -1.06 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | 43.33 Thousand | 188.54 Thousand | 33.17 Thousand | 22.08 Thousand | 43 Thousand |
| Gross Profit | - | -43.33 Thousand | -188.54 Thousand | -33.17 Thousand | -22.08 Thousand | -43 Thousand |
| Operating Expenses | 1.49 Million | 1.08 Million | 7.97 Million | 983.67 Thousand | 1.39 Million | 1.76 Million |
| Selling, General and Administrative Expenses | 817.91 Thousand | 512.14 Thousand | - | 484.84 Thousand | 510.1 Thousand | 722.3 Thousand |
| Research and Development Expenses | 67.68 Thousand | 73.64 Thousand | - | 134.13 Thousand | 569.71 Thousand | 667.91 Thousand |
| Other Expenses | 608.09 Thousand | - | - | - | - | - |
| Cost and Expenses | 1.49 Million | 1.08 Million | 8.16 Million | 983.67 Thousand | 1.39 Million | 1.76 Million |
| Operating Income | -3.12 Million | 873.3 Thousand | -8.16 Million | -4.61 Million | -1.38 Million | -1.75 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1.66 Million | 1.93 Million | -4.00 | -3.68 Million | -59.94 Thousand | -69.81 Thousand |
| Earnings before Tax | 170.06 Thousand | -3.01 Million | -2.91 Million | 2.69 Million | -1.33 Million | -1.69 Million |
| Net Income | 170.06 Thousand | -3.01 Million | -2.91 Million | 2.69 Million | -1.33 Million | -1.69 Million |
| Earnings Per Share Basic | 0.07 | -1.24 | - | 1.22 | -0.67 | -0.85 |
| Earnings Per Share Diluted | 0.07 | -1.24 | - | 1.22 | -0.67 | -0.85 |
| Weighted Average Shares Outstanding | 2.42 Million | 2.42 Million | 1.98 Million | 2.2 Million | 1.99 Million | 1.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.42 Million | 2.42 Million | 1.98 Million | 2.2 Million | 1.99 Million | 1.99 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -3.08 Million | 905.43 Thousand | - | -4.59 Million | -1.37 Million | -1.72 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
NCTW
FSV
QBY
NEM
002116
BKQNF